Lifeboat Foundation

• An advisory council has urged the U.S. to establish a new body that creates plans for national biodefense and to set aside a $2 billion standby fund to address emerging bioterror threats.
• As gene editing technology advances, the potential for its use as a weapon increases, and preparing for such threats before they happen is of the utmost importance.

Though the technology promises seemingly innumerable ways to positively impact human life, gene editing is truly a double-edged sword, with nearly as many potentially negative consequences as benefits. Now, an advisory council to President Obama is urging the government to start creating countermeasures for the negative use of emerging biotechnologies.

This month, the President’s Council of Advisors on Science and Technology (PCAST) wrote a letter to President Obama recommending measures to address this potential for harm using new technologies. It advocates funding new research into antibiotic and antiviral drugs to combat resistance and having a $250 million fund for the stockpiling of vaccines.

Bandages which can detect how a wound is healing and send messages back to doctors could be trialled within the next 12 months, scientists have said.

The bandages would use real-time 5G technology to monitor what treatment is needed and also keep track of a patient’s activity levels.

The work is being led by Swansea University’s Institute of Life Science.

Continue reading “Swansea University smart bandage trials ‘within 12 months’” »

A short summary of the recent senescent cell removal therapy being developed by a team in the Netherlands.

A quick summary of the new FOXO4 senescent cell removal therapy by Dr. Oliver Medvedik from LEAF.

We all know how to get pregnant or at least should know, but despite so many tips out there boosting the chances of conceiving, the actual first 2 weeks of pregnancy remain an undetectable mystery to science.

A pregnancy test is usually done via markers detecting hormones in specific substances like urine and blood. At the very beginning, though, these hormone levels are just too low to register a positive test. Without actually looking into the womb, nobody can watch fertilized eggs grow. Yes, we understand the process going on, as the embryo (which is basically a mass of cells called blastocyst) starts dropping its outer layer to implant within the uterine lining.

However, only a couple of weeks ago researchers from Rockefeller University were the first to witness and even raise human embryos in a laboratory for the maximum ethically allowable time of 13 days.

Continue reading “First Artificial Wombs: Researchers now grow human embryos in a laboratory to study pregnancy” »

Happy Easter…and a reality check: https://motherboard.vice.com/en_us/article/where-were-going-we-dont-need-popes #transhumanism #reason

Modern values, transhumanist technology, and the embrace of reason are making many Catholic rules and rituals absurd.

Everywhere I look, Pope Francis, the 266th pope of the Catholic Church, seems to be in the news—and he is being positively portrayed as a genuinely progressive leader. Frankly, this baffles me. Few major religions have as backwards a philosophical and moral platform as Catholicism. Therefore, no leader of it could actually be genuinely progressive. Yet, no one seems to pay attention to this—no one seems to be discussing that Catholicism remains highly oppressive.

Continue reading “The Transhumanist Future Has No Pope” »

A few weeks ago we unveiled the latest eight companies that are part of our URBAN-X smart cities accelerator in Brooklyn. This is the second time we’ve run this program, which differs a little from SOSV’s other ecosystem accelerators, in that the space isn’t constrained by the deep intricacies of a vertical (manufacturing, biotechnology, etc) as much as by environment and mission. The kind of companies we’re interested in working with through this program are changing the way that humans live in cities: they’re working on topics as various as mobility, urban health and safety, energy, waste, water, city planning, construction, and beyond.

We see hundreds of applicants to our program, and interface with hundreds more through our network, mentors, and co-investors. Here are some of the trends we’ve seen ticking up over the last 12 months or so:

Doctors have lots of tools for predicting a patient’s health. But—as even they will tell you—they’re no match for the complexity of the human body. Heart attacks in particular are hard to anticipate. Now, scientists have shown that computers capable of teaching themselves can perform even better than standard medical guidelines, significantly increasing prediction rates. If implemented, the new method could save thousands or even millions of lives a year.

“I can’t stress enough how important it is,” says Elsie Ross, a vascular surgeon at Stanford University in Palo Alto, California, who was not involved with the work, “and how much I really hope that doctors start to embrace the use of artificial intelligence to assist us in care of patients.”

Each year, nearly 20 million people die from the effects of cardiovascular disease, including heart attacks, strokes, blocked arteries, and other circulatory system malfunctions. In an effort to predict these cases, many doctors use guidelines similar to those of the American College of Cardiology/American Heart Association (ACC/AHA). Those are based on eight risk factors—including age, cholesterol level, and blood pressure—that physicians effectively add up.

Continue reading “Self-taught artificial intelligence beats doctors at predicting heart attacks” »

“A future without animal testing is getting closer. On Tuesday, the Food and Drug Administration agreed to a research-and-development collaboration with Emulate, a company that makes “organs-on-chips” technology.

The hope is that instead of testing new drugs or supplements on animals, researchers can use Emulate’s chips.

To start, the collaboration between the FDA and Emulate will focus on the company’s Liver-Chips, which are meant to show how an animal’s liver may react to a certain drug.

Continue reading “The FDA Just Struck a Deal That Could Replace Animal Testing With a Tiny Chip” »

A team of researchers led by Caltech’s Hyuck Choo has developed an eye implant for glaucoma patients that could one day lead to more timely and effective treatment.

If you have ever been to an ophthalmologist, you have probably had your eye pressure checked: with your chin resting on a support to keep your head still, the doctor applies pressure to your eye either via a puff of warm air or by gently pressing a probe against the eye’s surface. By measuring the amount that surface deforms as a result of a known amount of pressure, the ophthalmologist can calculate a rough estimate of the intraocular pressure.

While effective enough for routine eye exams, the technique is not sufficient for patients suffering from glaucoma. Glaucoma affects more than 2 million people in the United States, and is the second leading cause of blindness after cataracts. It is actually a family of eye diseases that are characterized by an increase in the pressure of the fluid inside the eye. That pressure damages the optic nerve at the back of the eye.

Continue reading “Black silicon prevents eye implant from gumming up” »